Literature DB >> 18089854

Hypoxia transcriptionally induces macrophage-inflammatory protein-3alpha/CCL-20 in primary human mononuclear phagocytes through nuclear factor (NF)-kappaB.

Florinda Battaglia1, Silvana Delfino, Elisa Merello, Maura Puppo, Roberto Piva, Luigi Varesio, Maria Carla Bosco.   

Abstract

Hypoxia, a condition of low oxygen tension, occurring in many pathological processes, modifies the mononuclear phagocyte transcriptional profile. Here, we demonstrate hypoxic up-regulation of the CCL20 chemokine in primary human monocytes (Mn) and macrophages. mRNA induction was paralleled by protein secretion and dependent on gene transcription activation. Functional studies of the CCL20 promoter using a series of 5'-deleted and mutated reporter constructs demonstrated the requirement for the NF-kappaB-binding site located at position -92/-82 for gene transactivation by hypoxia, as 1) transcription was abrogated by a 3-bp mutation of the NF-kappaB motif; 2) three copies of the wild-type NF-kappaB-binding site conferred hypoxia responsiveness to a minimal heterologous promoter; and 3) hypoxia increased specific NF-kappaB binding to this sequence. Furthermore, we provide evidence of the specific role of a single NF-kappaB family member, p50, in mediating CCL20 gene transcription in hypoxic Mn. p50 homodimers were the only detectable NF-kappaB complexes binding the cognate kappaB site on the CCL20 promoter upon hypoxia exposure, and NF-kappaBp50 knockdown by lentiviral-mediated short hairpin RNA interference resulted in complete binding inhibition. NF-kappaBp50 overexpression in transient cotransfection studies promoted CCL20 gene transactivation, which was abrogated by mutation of the -92/-82 kappaB site. Moreover, nuclear expression of the other NF-kappaB family members was inhibited in hypoxic Mn. In conclusion, this study characterizes a previously unrecognized role for hypoxia as a transcriptional inducer of CCL20 in human mononuclear phagocytes and highlights the importance of the NF-kappaB pathway in mediating this response, with potential implications for inflammatory disease and cancer pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18089854     DOI: 10.1189/jlb.0607349

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  21 in total

Review 1.  Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans.

Authors:  Leonid S Metelitsa
Journal:  Clin Immunol       Date:  2010-11-20       Impact factor: 3.969

2.  CARMA3 Is Critical for the Initiation of Allergic Airway Inflammation.

Authors:  Benjamin Causton; Ravisankar A Ramadas; Josalyn L Cho; Khristianna Jones; Ana Pardo-Saganta; Jayaraj Rajagopal; Ramnik J Xavier; Benjamin D Medoff
Journal:  J Immunol       Date:  2015-06-03       Impact factor: 5.422

Review 3.  Vascular endothelial growth factor signaling in hypoxia and inflammation.

Authors:  S Ramakrishnan; Vidhu Anand; Sabita Roy
Journal:  J Neuroimmune Pharmacol       Date:  2014-03-09       Impact factor: 4.147

4.  Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-κB signaling pathway.

Authors:  Peng Jin; Seung-Hyun Shin; Yang-Sook Chun; Hyun-Woo Shin; Yong Jae Shin; Yeri Lee; Donggeon Kim; Do-Hyun Nam; Jong-Wan Park
Journal:  Oncogene       Date:  2018-03-14       Impact factor: 9.867

5.  OX40 induces CCL20 expression in the context of antigen stimulation: an expanding role of co-stimulatory molecules in chemotaxis.

Authors:  Wenwei Zhong; Zili Zhang; David Hinrichs; Xiumei Wu; Mark Hall; Zhenwei Xia; James T Rosenbaum
Journal:  Cytokine       Date:  2010-04-18       Impact factor: 3.861

Review 6.  Hypoxia: a double-edged sword of immunity.

Authors:  Antonio Sica; Giovanni Melillo; Luigi Varesio
Journal:  J Mol Med (Berl)       Date:  2011-02-19       Impact factor: 4.599

7.  Mutations in BALB mitochondrial DNA induce CCL20 up-regulation promoting tumorigenic phenotypes.

Authors:  James Sligh; Jaroslav Janda; Jana Jandova
Journal:  Mutat Res       Date:  2014-11       Impact factor: 2.433

8.  Syk mediates IL-17-induced CCL20 expression by targeting Act1-dependent K63-linked ubiquitination of TRAF6.

Authors:  Nan-Lin Wu; Duen-Yi Huang; Hsin-Ni Tsou; Ying-Cing Lin; Wan-Wan Lin
Journal:  J Invest Dermatol       Date:  2014-09-09       Impact factor: 8.551

9.  IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity.

Authors:  Daofeng Liu; Liping Song; Jie Wei; Amy N Courtney; Xiuhua Gao; Ekaterina Marinova; Linjie Guo; Andras Heczey; Shahab Asgharzadeh; Eugene Kim; Gianpietro Dotti; Leonid S Metelitsa
Journal:  J Clin Invest       Date:  2012-05-08       Impact factor: 14.808

10.  The l1-l2 regularization framework unmasks the hypoxia signature hidden in the transcriptome of a set of heterogeneous neuroblastoma cell lines.

Authors:  Paolo Fardin; Annalisa Barla; Sofia Mosci; Lorenzo Rosasco; Alessandro Verri; Luigi Varesio
Journal:  BMC Genomics       Date:  2009-10-15       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.